J&J Buys Pfizer Consumer Division For $16.6 Bil.

Johnson & Johnson CEO William Weldon says the deal will make the firm's portfolio "more balanced," with 40% devoted to pharmaceuticals, 35% to medical devices and 25% to consumer products.